Effectiveness and safety of anticoagulants among patients with venous thromboembolism and active cancer who also had prior bleed or prior renal disease
CONCLUSION: The incidence of MB was higher among those with prior bleed or renal disease. Effects of apixaban, warfarin, or LMWH were generally consistent regardless of prior bleed or renal disease status.PMID:38332714 | DOI:10.1080/03007995.2024.2313092
Source: Current Medical Research and Opinion - Category: Research Authors: Alexander T Cohen Virginia Noxon Amol D Dhamane Shrushti Shah Dionne M Hines Tamuno Alfred Jos é Chaves Xuemei Luo Source Type: research
More News: Bleeding | Cancer | Cancer & Oncology | Coumadin | Databases & Libraries | Research | Study | Thrombosis | USA Health | Warfarin